Chunyan Wu

机构：Tongji University, Shanghai Pulmonary Hospital, Jiangsu Province Hospital, Nanjing Medical University · ORCID：0000-0003-4488-8956

发表论文 113 篇 · 总被引 3998 次 · h-index 30

代表论文

• Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies (2024 · Cell · 被引 189)
• Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer (2024 · Nature Genetics · 被引 146)
• Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II–III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trial (2022 · BMC Medicine · 被引 68)
• CXCR1+ neutrophil infiltration orchestrates response to third-generation EGFR-TKI in EGFR mutant non-small-cell lung cancer (2024 · Signal Transduction and Targeted Therapy · 被引 17)
• Real‐world data on ALK rearrangement test in Chinese advanced non‐small cell lung cancer (RATICAL): a nationwide multicenter retrospective study (2024 · 癌症：英文版 · 被引 11)
• Primary Extraosseous Ewing Sarcoma on 18F-FDG and 68Ga-FAPI-04 PET/CT (2024 · Clinical Nuclear Medicine · 被引 9)